Document Type

Article

Publication Date

4-30-2024

Identifier

DOI: 10.22551/2024.42.1101.10281; PMCID: PMC11060144

Abstract

We describe the natural history of a three-month-old patient with Hunter Syndrome with hematopoietic stem cell transplant (HSCT) who developed recurrent diffuse alveolar hemorrhage (DAH) requiring extracorporeal membrane oxygenation (ECMO). The patient underwent HSCT with several complications, including veno-occlusive disease and DAH. He was managed with ECMO. Unfortunately, despite initial success he developed recurrent DAH and ultimately died. This is a novel report of this severe adverse event requiring ECMO following the use of HSCT in this rare patient population. We share the clinical strategies employed to address the complications associated with HSCT and the progression of his disease over his hospitalization.

Journal Title

Arch Clin Cases

Volume

11

Issue

1

First Page

19

Last Page

21

Keywords

Hunter's syndrome; bone marrow transplant; diffuse alveolar hemorrhage (DAH); extra corporal membrane oxygenation (ECMO); pulmonary hemorrhage

Comments

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publisher's Link: https://www.clinicalcases.eu/index.php/acc/article/view/1075

Download

Share

COinS